{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:53:41Z","timestamp":1761166421727,"version":"build-2065373602"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jmgm.2017.08.004","type":"journal-article","created":{"date-parts":[[2017,8,12]],"date-time":"2017-08-12T08:15:13Z","timestamp":1502525713000},"page":"240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Publisher's note"],"prefix":"10.1016","volume":"77","member":"78","reference":[{"year":"2013","series-title":"A Global Brief on Hypertension: Silent Killer, Global Public Health Crisis","author":"WHO","key":"10.1016\/j.jmgm.2017.08.004_bib0005"},{"key":"10.1016\/j.jmgm.2017.08.004_bib0010","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1016\/j.bmc.2010.10.043","article-title":"Angiotensin II receptor type 1 (AT 1) selective nonpeptidic antagonists\u2014A perspective","volume":"18","author":"Naik","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0015","series-title":"Renin Angiotensin System and Cardiovascular Disease","first-page":"59","article-title":"AT1 receptors, angiotensin receptor blockade, and clinical hypertensive disease","author":"Carey","year":"2009"},{"key":"10.1016\/j.jmgm.2017.08.004_bib0020","series-title":"Comprehensive Physiology","article-title":"Pathophysiology of primary hypertension","author":"Carey","year":"2008"},{"key":"10.1016\/j.jmgm.2017.08.004_bib0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology: XXIII. The angiotensin II receptors","volume":"52","author":"De Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0030","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10822-010-9371-3","article-title":"An efficient synthesis of a rationally designed 1, 5 disubstituted imidazole AT1 angiotensin II receptor antagonist: reorientation of imidazole pharmacophore groups in losartan reserves high receptor affinity and confirms docking studies","volume":"24","author":"Agelis","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0035","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/sj.bjc.6605866","article-title":"Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma","volume":"103","author":"Dolley-Hitze","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jmgm.2017.08.004_bib0040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0014-2999(95)00762-8","article-title":"Alterations in angiotensin AT1 and AT2 receptor subtype levels in brain regions from patients with neurodegenerative disorders","volume":"297","author":"Ge","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0045","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1021\/jm00100a007","article-title":"New nonpeptide angiotensin II receptor antagonists 2. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy) quinoline derivatives","volume":"35","author":"Bradbury","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0050","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0140-6736(02)08062-5","article-title":"Angiotensin blockade for hypertension: a promise fulfilled","volume":"359","author":"Brunner","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jmgm.2017.08.004_bib0055","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1021\/jm7011563","article-title":"Design, synthesis, and biological evaluation of AT1 angiotensin II receptor antagonists based on the pyrazolo [3, 4-b] pyridine and related heteroaromatic bicyclic systems","volume":"51","author":"Cappelli","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0060","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2165\/00003495-200262080-00016","article-title":"Candesartan cilexetil","volume":"62","author":"Easthope","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.jmgm.2017.08.004_bib0065","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1021\/jm050232e","article-title":"Design and synthesis of new tetrazolyl-and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists","volume":"49","author":"Ismail","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0070","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-3565(24)38951-7","article-title":"Tasosartan, enoltasosartan, and angiotensin II receptor blockade: the confounding role of protein binding","volume":"295","author":"Maillard","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0075","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1021\/jm00061a014","article-title":"Molecular shape comparison of angiotensin II receptor antagonists","volume":"36","author":"Masek","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0080","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.3390\/molecules20033868","article-title":"Rational drug design and synthesis of molecules targeting the angiotensin II type 1 and type 2 receptors","volume":"20","author":"Kellici","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2017.08.004_bib0085","first-page":"36","article-title":"Leveraging NMR and X-ray data of the free ligands to build better drugs targeting angiotensin II type 1 G-Protein coupled receptor","volume":"23","author":"Tahsin","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0090","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1021\/ci300353u","article-title":"Modeling of open, closed, and open-inactivated states of the hERG1 channel: structural mechanisms of the state-dependent drug binding","volume":"52","author":"Durdagi","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0095","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1021\/ci100409y","article-title":"Combined receptor and ligand-based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain","volume":"51","author":"Durdagi","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0100","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/jpet.111.189159","article-title":"Structure-guided topographic mapping and mutagenesis to elucidate binding sites for the human ether-a-go-go-related gene 1 potassium channel (KCNH2) activator NS1643","volume":"342","author":"Durdagi","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0105","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.2174\/092986710792927886","article-title":"Insights into the molecular mechanism of hERG1 channel activation and blockade by drugs","volume":"17","author":"Durdagi","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0110","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/prot.22815","article-title":"Structural refinement of the hERG1 pore and voltage-sensing domains with ROSETTA-membrane and molecular dynamics simulations","volume":"78","author":"Subbotina","year":"2010","journal-title":"Proteins: Struc. Funct. Bioinf."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0115","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cell.2017.03.048","article-title":"Cryo-EM structure of the open human ether-a-go-go-Related K+ channel hERG","volume":"169","author":"Wang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jmgm.2017.08.004_bib0120","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cell.2015.04.011","article-title":"Structure of the angiotensin receptor revealed by serial femtosecond crystallography","volume":"161","author":"Zhang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jmgm.2017.08.004_bib0125","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1021\/jm060338p","article-title":"Proposal of a new binding orientation for non-peptide AT1 antagonists: homology modeling, docking and three-dimensional quantitative structure-activity relationship analysis","volume":"49","author":"Tuccinardi","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0130","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jmb.2004.07.044","article-title":"The retinal conformation and its environment in rhodopsin in light of a new 2.2 \u00c5 crystal structure","volume":"342","author":"Okada","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0135","doi-asserted-by":"crossref","first-page":"29127","DOI":"10.1074\/jbc.M115.689000","article-title":"Structural basis for ligand recognition and functional selectivity at angiotensin receptor","volume":"290","author":"Zhang","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2016.11.014","article-title":"The dynamic properties of angiotensin II type 1 receptor inverse agonists in solution and in the receptor site","author":"Kellici","year":"2016","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0150","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/prot.22102","article-title":"Very fast prediction and rationalization of pKa values for protein\u2013ligand complexes","volume":"73","author":"Bas","year":"2008","journal-title":"Proteins: Struc. Funct. Bioinf."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0155","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/prot.20660","article-title":"Very fast empirical prediction and rationalization of protein pKa values","volume":"61","author":"Li","year":"2005","journal-title":"Proteins: Struc. Funct. Bioinf."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0160","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jcc.20292","article-title":"Integrated modeling program, applied chemical theory (IMPACT)","volume":"26","author":"Banks","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0165","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1021\/ct200908r","article-title":"Optimization of the OPLS-AA force field for long hydrocarbons","volume":"8","author":"Siu","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC-a free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0175","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","article-title":"Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution","volume":"24","author":"Greenwood","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0180","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK a prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0185","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring: 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0190","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0195","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring: 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0200","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved protein\u2013ligand docking using GOLD","volume":"52","author":"Verdonk","year":"2003","journal-title":"Proteins: Struc. Funct Bioinf."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0205","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature10939","article-title":"Structure of the human [kgr]-opioid receptor in complex with JDTic","volume":"485","author":"Wu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2017.08.004_bib0210","doi-asserted-by":"crossref","first-page":"e880","DOI":"10.1371\/journal.pone.0000880","article-title":"Automated builder and database of protein\/membrane complexes for molecular dynamics simulations","volume":"2","author":"Jo","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.jmgm.2017.08.004_bib0215","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field","volume":"12","author":"Lee","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0220","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jcc.23702","article-title":"CHARMM-GUI Membrane Builder toward realistic biological membrane simulations","volume":"35","author":"Wu","year":"2014","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0225","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/bioinformatics\/btk023","article-title":"OPM: orientations of proteins in membranes database","volume":"22","author":"Lomize","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmgm.2017.08.004_bib0230","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1110\/ps.062126106","article-title":"Positioning of proteins in membranes: a computational approach","volume":"15","author":"Lomize","year":"2006","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0235","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","article-title":"GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J. Chem. Theory Comput."},{"year":"2013","series-title":"GROMACS Version 4 6.5.","author":"van der Spoel","key":"10.1016\/j.jmgm.2017.08.004_bib0240"},{"key":"10.1016\/j.jmgm.2017.08.004_bib0245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0010-4655(95)00042-E","article-title":"GROMACS: a message-passing parallel molecular dynamics implementation","volume":"91","author":"Berendsen","year":"1995","journal-title":"Comput. Phys. Commun."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0250","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0255","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5 log (N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0260","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1103\/PhysRevA.31.1695","article-title":"Canonical dynamics: equilibrium phase-space distributions","volume":"31","author":"Hoover","year":"1985","journal-title":"Phys. Rev. A"},{"key":"10.1016\/j.jmgm.2017.08.004_bib0265","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jcc.21372","article-title":"Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA","volume":"31","author":"Rastelli","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.104.000497.","article-title":"G protein-coupled receptor dimerization: function and ligand pharmacology","volume":"66","author":"Milligan","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0275","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.embor.7400052","article-title":"Roles of G-protein-coupled receptor dimerization","volume":"5","author":"Terrillon","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0280","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1074\/jbc.M116.750380","article-title":"Differential contribution of transmembrane domains IV, V, VI, and VII to human angiotensin II type 1 receptor homomer formation","volume":"292","author":"Young","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0285","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1021\/acschemneuro.5b00271","article-title":"Binding interactions of dopamine and apomorphine in D2High and D2Low states of human dopamine D2 receptor using computational and experimental techniques","volume":"7","author":"Durdagi","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0290","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1745-7254.2008.00839.x","article-title":"Electropharmacological properties of telmisartan in blocking hKv1: 5 and HERG potassium chanenls expressed on Xenopus laevis oocytes","volume":"29","author":"Tu","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0295","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbamem.2013.12.012","article-title":"Insights into the molecular basis of action of AT1 antagonist losartan using a combined NMR spectroscopy and computational approach","volume":"2838","author":"Zervou","year":"2014","journal-title":"BBA Biomembr."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0300","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1007\/s00044-012-0464-5","article-title":"Molecular Insights into the AT1 antagonism based on biophysical and in silico studies of telmisartan","volume":"22","author":"Kritsi","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0305","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1517\/13543776.2013.830104","article-title":"AT1 antagonists: a patent reviewe (2008\u20132012)","volume":"23","author":"Mavromoustakos","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.jmgm.2017.08.004_bib0310","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ejmech.2012.07.040","article-title":"The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-buthylimidazole derivatives","volume":"55","author":"Agelis","year":"2012","journal-title":"Eur. J. Med. Chem."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326317305338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326317305338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:57:47Z","timestamp":1761080267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326317305338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":62,"alternative-id":["S1093326317305338"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2017.08.004","relation":{},"ISSN":["1093-3263"],"issn-type":[{"type":"print","value":"1093-3263"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Publisher's note","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2017.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}